Meanwhile, enhancer genes CAMTA2 and FOXD1 were identified from the signature, which expressed significantly higher in stage 4S than in stage 4, providing potential investigation values in the field of differentiation and spontaneous regression in NB. The gene discussed is FOXD1; the disease is neuroblastoma.